Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1973 Feb;49(568):73–76. doi: 10.1136/pgmj.49.568.73

Experimental approaches to endometrial and ovarian cancer.

M G Brush
PMCID: PMC2495337  PMID: 4580808

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astedt B., Svanberg L., Nilsson I. M. Fibrin degradation products and ovarian tumours. Br Med J. 1971 Nov 20;4(5785):458–459. doi: 10.1136/bmj.4.5785.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brush M. G., Taylor R. W., King R. J. The uptake of [6,7-3H]oestradiol by the normal human female reproductive tract. J Endocrinol. 1967 Dec;39(4):599–607. doi: 10.1677/joe.0.0390599. [DOI] [PubMed] [Google Scholar]
  3. CHARLES D., BELL E. T., LORAINE J. A., HARKNESS R. A. ENDOMETRIAL CARCINOMA--ENDOCRINOLOGICAL AND CLINICAL STUDIES. Am J Obstet Gynecol. 1965 Apr 15;91:1050–1059. doi: 10.1016/0002-9378(65)90701-5. [DOI] [PubMed] [Google Scholar]
  4. Crowley L. G. Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast. Calif Med. 1969 Jan;110(1):43–60. [PMC free article] [PubMed] [Google Scholar]
  5. Crowley L. G., Duwe S. A. Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors. Calif Med. 1969 Feb;110(2):139–150. [PMC free article] [PubMed] [Google Scholar]
  6. GUSBERG S. B., KAPLAN A. L. PRECURSORS OF CORPUS CANCER. IV. ADENOMATOUS HYPERPLASIA AS STAGE O CARCINOMA OF THE ENDOMETRIUM. Am J Obstet Gynecol. 1963 Nov 1;87:662–678. [PubMed] [Google Scholar]
  7. Gusberg S. B. Hormone-dependence of endometrial cancer. Obstet Gynecol. 1967 Aug;30(2):287–293. [PubMed] [Google Scholar]
  8. Hudson C. N., Stansfeld A. G. The histological changes produced in untreated adeno-carcinoma of the endometrium by a progestogen. J Obstet Gynaecol Br Commonw. 1967 Jun;74(3):442–444. doi: 10.1111/j.1471-0528.1967.tb03970.x. [DOI] [PubMed] [Google Scholar]
  9. KELLEY R. M., BAKER W. H. Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med. 1961 Feb 2;264:216–222. doi: 10.1056/NEJM196102022640503. [DOI] [PubMed] [Google Scholar]
  10. KENNEDY B. J. A progestogen for treatment of advanced endometrial cancer. JAMA. 1963 Jun 8;184:758–761. doi: 10.1001/jama.1963.03700230058009. [DOI] [PubMed] [Google Scholar]
  11. Kennedy B. J. Progestogens in the treatment of carcinoma of the endometrium. Surg Gynecol Obstet. 1968 Jul;127(1):103–114. [PubMed] [Google Scholar]
  12. LIGGINS G. C. PROGESTOGENS AS CLINICAL ANTI-OESTROGENS. N Z Med J. 1964 Jun;63:383–383. [PubMed] [Google Scholar]
  13. Nordqvist S. Survival and hormonal responsiveness of endometrial carcinoma in organ culture. Acta Obstet Gynecol Scand. 1970;49(3):275–283. doi: 10.3109/00016347009157251. [DOI] [PubMed] [Google Scholar]
  14. Phillips T. J. Oral progestogens and adenocarcinoma of the uterus. An account of 3 cases of advanced endometrial carcinoma treated with an oral progestogen. J Obstet Gynaecol Br Commonw. 1966 Jun;73(3):487–489. doi: 10.1111/j.1471-0528.1966.tb05194.x. [DOI] [PubMed] [Google Scholar]
  15. Taylor R. W., Brush M. G., King R. J. The use of oestradiol uptake and binding-site studies in endometrial and ovarian carcinoma. Postgrad Med J. 1973 Feb;49(568):77–77. doi: 10.1136/pgmj.49.568.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Taylor R. W., Brush M. G., King R. J., Witt M. The uptake of oestrogen by endometrial carcinoma. Proc R Soc Med. 1971 Apr;64(4):407–408. doi: 10.1177/003591577106400436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. VARGA A., HENRIKSEN E. Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma. Obstet Gynecol. 1961 Dec;18:658–672. [PubMed] [Google Scholar]
  18. VARGA A., HENRIKSEN E. EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES. Obstet Gynecol. 1964 Jan;23:51–62. [PubMed] [Google Scholar]
  19. Varga A., Henriksen E. Histologic observations on the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma. Obstet Gynecol. 1965 Nov;26(5):656–664. [PubMed] [Google Scholar]
  20. de Waard F., Thyssen J. H., Veeman W., Sander P. C. Steroid hormone excretion pattern in women with endometrial carcinoma. Cancer. 1968 Nov;22(5):988–993. doi: 10.1002/1097-0142(196811)22:5<988::aid-cncr2820220513>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES